Rapid Antidepressant Improvement Secondary to Excitatory Brain Responses
NCT: NCT04276259 · COMPLETED
Brief Summary
The central goal of this application is to demonstrate the causal contribution of reward learning signals (expected values and reward prediction errors \[RPE\]) to antidepressant responses (Aim1) by experimentally manipulating expected values using transcranial magnetic stimulation (TMS) targeting the vmPFC (Aim 2) and μ-opioid striatal RPE signal using pharmacological approaches (Aim 3).
Frequently Asked Questions
What is Rapid Antidepressant Improvement Secondary to Excitatory Brain Responses?
Rapid Antidepressant Improvement Secondary to Excitatory Brain Responses is a clinical trial registered under NCT04276259. Current status: COMPLETED.
What is the status of NCT04276259?
The current status of NCT04276259 (Rapid Antidepressant Improvement Secondary to Excitatory Brain Responses) is: COMPLETED.
When did Rapid Antidepressant Improvement Secondary to Excitatory Brain Responses start?
Rapid Antidepressant Improvement Secondary to Excitatory Brain Responses started on 2020-10-19.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.